HeimFAGR • EBR
add
Fagron NV
Við síðustu lokun
16,62 €
Dagbil
16,60 € - 16,84 €
Árabil
15,14 € - 20,05 €
Markaðsvirði
1,23 ma. EUR
Meðalmagn
62,62 þ.
V/H-hlutf.
15,83
A/V-hlutfall
1,25%
Aðalkauphöll
EBR
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 214,67 m. | 15,55% |
Rekstrarkostnaður | 64,58 m. | 17,26% |
Nettótekjur | 20,21 m. | 22,37% |
Hagnaðarhlutfall | 9,42 | 5,96% |
Hagnaður á hvern hlut | — | — |
EBITDA | 37,71 m. | 18,42% |
Virkt skatthlutfall | 21,39% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 98,26 m. | -17,44% |
Heildareignir | 1,05 ma. | 1,99% |
Heildarskuldir | 567,95 m. | -2,78% |
Eigið fé alls | 477,11 m. | — |
Útistandandi hlutabréf | 72,99 m. | — |
Eiginfjárgengi | 2,56 | — |
Arðsemi eigna | 7,61% | — |
Ávöxtun eigin fjár | 9,35% | — |
Peningaflæði
Breyting á handbæru fé
| (EUR) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 20,21 m. | 22,37% |
Handbært fé frá rekstri | 20,96 m. | -3,11% |
Reiðufé frá fjárfestingum | -21,80 m. | -64,37% |
Reiðufé frá fjármögnun | -16,21 m. | 0,37% |
Breyting á handbæru fé | -18,16 m. | -176,76% |
Frjálst peningaflæði | 15,04 m. | 31,59% |
Um
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
Framkvæmdastjóri
Stofnsett
1990
Vefsvæði
Starfsfólk
3.647
